We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov
ClinicalTrials.gov Menu

The Regression of Liver Fibrosis and Risk for Hepatocellular Carcinoma (ROLFH) Study (ROLFH)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01831037
Recruitment Status : Withdrawn (Unable to obtain funding)
First Posted : April 15, 2013
Last Update Posted : January 28, 2015
Sponsor:
Collaborators:
University of North Carolina, Chapel Hill
University of Toronto
University of Calgary
Information provided by (Responsible Party):
University of Arkansas

No Study Results Posted on ClinicalTrials.gov for this Study
Study was withdrawn before participants were enrolled.
  Recruitment Status : Withdrawn
  Estimated Primary Completion Date : June 2019
  Estimated Study Completion Date : December 2019